Show
Sort by
-
Interobserver variation in the assessment of immunohistochemistry expression levels in HER2-negative breast cancer : can we improve the identification of low levels of HER2 expression by adjusting the criteria? An international interobserver study
-
A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer
-
Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression
-
Second hit landscape in BRCA-associated breast cancer
-
Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting